Part:BBa_K2404016:Design
A TSH antagonist with His-Tags, controlled by the LexA promoter
- 10INCOMPATIBLE WITH RFC[10]Illegal PstI site found at 22
Illegal PstI site found at 888
Illegal PstI site found at 930 - 12INCOMPATIBLE WITH RFC[12]Illegal PstI site found at 22
Illegal PstI site found at 888
Illegal PstI site found at 930 - 21INCOMPATIBLE WITH RFC[21]Illegal BamHI site found at 1143
Illegal XhoI site found at 955 - 23INCOMPATIBLE WITH RFC[23]Illegal PstI site found at 22
Illegal PstI site found at 888
Illegal PstI site found at 930 - 25INCOMPATIBLE WITH RFC[25]Illegal PstI site found at 22
Illegal PstI site found at 888
Illegal PstI site found at 930 - 1000COMPATIBLE WITH RFC[1000]
Design Notes
Experimental design for composite part construction:
We conducted a Type IIS restriction enzyme digest using the BsaI enzyme. The reaction mix includes three level 0 plasmid
> Restriction digest at 37C
- BsaI
- Enzyme buffer
- Level 0 plasmid containing LexA
- Level 0 plasmid containing NosT
- Level 0 plasmid containing TSHH
- Level 1 plasmid pGB-A2
> Inactivate enzyme at 80C
> Add T4 ligase
> Transform E.coli and plate onto kanamycin (50ug/ul) plates
This part was created using golden gate assembly, and thus has typeIIS restriction enzyme recognition sites flanking it.
Source
The CDS was synthesised, and the promoter and terminator isolated from gDNA of E. coli and Agrobacterium tumefaciens , respectively.